Investment Q&A

Q: What did you think of their quarterly report out this morning ?

Thanks

Q: Hi,
Is Dirtt buyable today at about $8.48 Or wait for it to maybe settle some more after the big run up.

Thank you

Q: Hi Peter,

Given what's going on with lawsuits and other pressures at GXI:

http://business.financialpost.com/news/fp-street/will-defamation-suit-proxy-battle

What's your take on all of this noise?

Q: Can I get your updated views on Lumenpulse? Previous comments seem to suggest you are warming up to it, but the stock hasn't done much in the past 6 months. What would be a catalyst to provide some positive stock momentum?

Thanks!

Q: After earnings release, stock opened higher then dropped a lot. What is your opinion on buy, hold or sell.
Thank you.

Q: Hi Peter and team,
As a small cap,is its growth sustainable? Or it may be a potential target of acquisition?
Thanks!
Jim

Q: Hi Team

I was wondering what you know about HRX, seems like it has good rating from Scotia bank. Is it a buy at this price . and what can you tell me about it

Q: Good Evening, I would like to ask about Guestlogix. I am curious about them because of what they offer in the airline industry. When you think about it, when one goes to the airport they almost always have to purchase something, such as food, because it is more of a hassle trying to get it through the gate. Anyways, would appreciate your input on this company.
Seamus

Q: PLEASE advise as to your opinion on the growth of this co.
thank you JACK

Q: Please provide comments on AIM as being appropriate in an income portfolio.

Q: Prometic is scheduled to release its fourth quarter results at the close today. Could you please advise if there are any analyst expectations with respect to this company? Thank you, Peter

Q: I have had a nice pop on this stock(FTG Firan).Can you give me some advise going forward.Thanks

Q: I wonder if you can comment on the latest earnings report from Savaria. It would seem to warrant a more positive share price reaction.

Q: After experiencing healthy gains in Patient Home Monitoring, I read through the entire Convalo Health website to learn about their company. Their plans has some good potential but seems to rely heavily on new insurance-paid therapies. If the Republicans win the next election and skewer Obama's healthcare plan, will this significantly affect Convalo's business model? Second, they presently have one location where they have increased sales from $80K to $300K and around $5M in cash. I assume they will have to do a "healthy" raise to grow similar to PHM.
Your analysis would be appreciated.
Thanks.

Q: The last question on DDC was Nov 13/13, at which time you called it an OK - type of company. It appears since then to have changed for the better. Certainly it is doing better than most of its peers. Thru my bank acct I have access to Value Engine analysis of DDC. According to them DDC's fair market value is $37. So I'm thinking this may be a good buy. I'm not sure how to interpret their balance sheet, however There is no line that says "debt" - just a comparison of Assets to Liabilities; which to my untrained eyes looks pretty good(assets=3x liabilities).So what are the debt issues, if any with this company? Are there any other red flags I should be aware of? Lastly, how do view DDC today.
Thankyou----I really enjoy your service.

Q: I'm up over 300%. It was a very conservative buy in the first place, so even with gain, it is a reasonable position in my portfolio. I read a report this weekend that they may not be completely forthcoming with their income statement, that Net Operating Profit in Q1 2015 was listed as $1.572 million, but the fine print indicated that this figure excluded the amortization of intangible assets, stock-based compensation, the gain or loss on derivative financial liability, interest expense, and income tax expense. With the inclusion of these expenses, Q1 would present quite differently. Is this an ethical presentation, and should I be concerned with holding this stock? How does the balance sheet look? Because of my small position, I had planned on holding for a couple of years and riding out the volatility, but of course it's a shame to lose the gain if they are not presenting the true picture, and the stock is weaker than it appears. Your opinion please. Thank-you.

Q: What do you make of their latest financial report? Would you buy this stock now? Thank you.

Q: I know you like Knight Therapeutics. Stock has been hit quite hard recently, and currently is trading around $8. Do you think it's a good entry price here? Also is it a safe stock to hold in a RESP account? (My kids are quite young, so the money inside RESP won't be cashed for minimum 10 years.)Thanks for your great advice!

Q: Have you guys done any research on this company, opinions?

Q: Hello, could we have your thoughts on the current valuation and prospects for Savaria. It is approaching 6 per cent of my portfolio which is pretty high for a company of this size I think. Thanks.